Artificial intelligence (AI) and automation are no longer futuristic concepts in pharmacovigilance – they are becoming operational necessities.
From accelerating signal detection to improving risk-benefit assessments, tools like Veeva Systems’ AI-enabled safety solutions bring unmatched speed, scalability, and analytical depth.
Our bulletin explores:
- How NLP, machine learning, and automation enhance safety workflows
- Veeva’s new AI-driven capabilities in signal management
- Challenges around validation, transparency, and compliance
- Future trends such as explainable AI and federated learning
At Biomapas, we see AI and automation not as standalone tools, but as integral components of an efficient, scalable, and compliant PV system.
